Literature DB >> 12640655

Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats.

Neville N C Tam1, Shibnath Ghatak, Shuk-Mei Ho.   

Abstract

BACKGROUND: Oxidative stress has been implicated in prostate carcinogenesis. In the Noble rat model, treatment of rats with testosterone (T) plus 17beta-estradiol (E(2)) induced dysplasia and adenocarcinoma. Previous reports from us and other have indicated a linkage between steroid hormones and oxidative status in prostate cells in vivo and in vitro. Here, we provide further evidence that androgens and estrogens could induce a lobe-specific shift of prooxidant-antioxidant balance and alterations in antioxidant enzyme activities, leading to oxidative stress in the rat prostate gland in vivo.
METHODS: Male Noble rats were subjected to single (T, E(2), or diethylstilbestrol [DES] alone) or combined (T + E(2) or T + DES) hormone treatments. Lipid peroxidation status and antioxidant enzyme activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione reductase (GR), glucose-6-phosphate dehydrogenase (G6PD) were assayed spectrophotometrically.
RESULTS: Treatment of rats with T did not alter lipid peroxidation in either the ventral prostate (VP) or the dorsolateral prostate (DLP). In contrast, exposure of rats to DES or E(2) modestly elevated lipid peroxidation in rat VP or DLP, respectively. Of importance, T + DES and T + E(2) treatments of rats induced marked increases in lipid peroxidation in the VP and the DLP, respectively. Antioxidant enzyme activities in the VP and DLP exhibited differential responses to sex hormone challenges. The activities of catalase, GPx, GR, and G6PD were mostly suppressed in either single or dual hormone-treated DLP, whereas there is a general increase of GR and G6PD activities in the VP after hormonal exposures. The changes in T + DES-treated VP were most dramatic with a marked activation of GPx (by one-fold), GR (by one-fold), and G6PD (by five-fold).
CONCLUSION: The lobe-specific differential responses of hormone-induced oxidative stress and modulations of antioxidant enzymatic defenses in the rat prostate suggest that reactive oxygen species may play a role in hormone-induced prostate carcinogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640655     DOI: 10.1002/pros.10169

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  15 in total

Review 1.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.

Authors:  Nur Ozten; Lori Horton; Salamia Lasano; Maarten C Bosland
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

Review 3.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

4.  Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

Authors:  Yuet-Kin Leung; Paul Mak; Sazzad Hassan; Shuk-Mei Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

5.  Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.

Authors:  Neville N C Tam; Irwin Leav; Shuk-Mei Ho
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

6.  L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats.

Authors:  Nur Özten; Michael Schlicht; Alan M Diamond; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2014-04-28       Impact factor: 2.900

7.  Osteocyte apoptosis and control of bone resorption following ovariectomy in mice.

Authors:  K B Emerton; B Hu; A A Woo; A Sinofsky; C Hernandez; R J Majeska; K J Jepsen; M B Schaffler
Journal:  Bone       Date:  2009-11-17       Impact factor: 4.398

8.  Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.

Authors:  Neville N C Tam; Carol Ying-Ying Szeto; Maureen A Sartor; Mario Medvedovic; Shuk-Mei Ho
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

Review 9.  [Pathophysiology and therapy of benign prostatic hyperplasia].

Authors:  Natalie Sampson; Stephan Madersbacher; Peter Berger
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 10.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.